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ABSTRACT 
Colorectal cancer is the fourth most common cancer worldwide, with a lifetime risk of around 20%. 
Current technology available at endoscopy and peri-operatively do not allow the clinician to provide 
an indication of the likelihood of malignancy. There is, therefore, a need for novel diagnostic 
techniques to detect malignant lesions at an early stage. Given the new developments in minimally 
invasive diagnostics and management strategies, real-time point-of-care technology represents a 
potential area for further research into improving diagnosis and influencing management of 
colorectal cancer. Electrical impedance spectroscopy (EIS) has been shown to accurately 
discriminate malignant lesions in other cancers. We present a feasibility study for the real-time 
detection of malignant colorectal tissue using EIS. This prospective ex-vivo pilot study used a 
Zedscan device to obtain EIS measurements from excised human colorectal tumour tissue and 
matched normal colonic mucosa in 22 freshly resected specimens following elective surgery for 
colorectal cancer. Histopathological examination was used to confirm the final diagnosis. Statistical 
significance was assessed with the Wilcoxon signed rank test. Twenty-two colorectal resection 
specimens were tested with EIS. Three were excluded as final histopathology did not identify 
colorectal adenocarcinoma. EIS was able to  discriminate cancer with statistically significant results 
when applying frequencies over 152KHz  (p < 0.05). At a cut-off level of 350 Ω, the area under the 
receiver operating characteristic curve was 0.7097. This preliminary study demonstrates that EIS 
changes in colorectal tissue are detectable and statistically significant, suggesting that EIS has the 
potential as a novel non-invasive point of care test for detecting colorectal cancer.  
Keywords: cancer, colorectal, electrical impedance spectroscopy (EIS), diagnosis, real-time
1 Introduction  
Colorectal cancer (CRC) is a leading cause of global cancer-related mortality in men and women 
with over 1 million new cases diagnosed annually worldwide (Cunningham et al., 2010). It is the 
fourth most common cancer worldwide, with a lifetime risk of around 20%. Complete surgical 
resection remains the only curative option for management of CRC and is combined with chemo 
and/or radiotherapy in selected cases (Andre N et al,. 2005). The past 30 years have seen a 
significant shift towards increasingly ‘minimal access’ surgical approaches (minimally invasive 
surgery, MIS), and laparoscopic surgical techniques are now routinely employed in the operative 
management of cancers of the colon (Jayne DG et al., 2007) and rectum (Chand Chand M et al., 
2012). Endoluminal cancer excision is an extension of this philosophy and represents the next 
major objective on the MIS road-map, offering a further reduction in surgical invasiveness by 
permitting cancer lesion removal by completely ‘scarless’ means. Here, tumours are approached 
and removed via the bowel lumen using an operating endoscope, such as in endoscopic mucosal 
resection (Woodward TA et al., 2012, Waye JD et al., 2001) or a proctoscope in transanal 
endoscopic microsurgery (De Graaf EJ et al., 2002). These approaches are technically demanding 
but appear to result in reduced post-operative morbidity (De Graaf EJ et al., 2009). There have 
been recent advances in endoscopic technology that have been working towards providing more 
real-time information for the clinician, such as chromoendoscopy, narrow-band imaging and, most 
recently, the iKnife (Mcgill et al, 2013 and Balog et al, 2013). However, a reliable, quantitative 
measure of tissue abnormality at initial endoscopy or that of intraoperative resection margins which 
is tissue sparing remains to be achieved. Histopathological assessment of excised tissue samples 
therefore remains the gold standard. However, as this assessment relies on various steps which 
each take time (Loughrey et al, 2014), histopathological assessment does result in a time delay 
prior to a definitive tissue diagnosis. 
1.1 Electrical Impedance Spectroscopy (EIS) 
The main focus of this paper evaluates the use of electrical impedance spectroscopy (EIS) to 
assess whether bioimpedance measurements could be used to differentiate colorectal cancer from 
benign colonic mucosa. Of particular interest to our clinical work is the possibility of the detection of 
these types of cancer during endoscopic and surgical procedures as a predictor of recurrence, 
including lymph node involvement, poor differentiation, perineural invasion, and vascular invasion. 
A major advantage of this approach over previously proposed methods is the ability to provide 
instant information regarding the state for the tissue, equivalent to a biopsy, without requiring any 
alteration to the tissue being measured. The detection of cancer pathology in the tissue using 
bioimpedance measurements, and particularly cervical cancer, has been reported in literature (S. 
Abdul et al, 2005, Abdul et al, 2006 and JA Tidy et al, 2013) in which tetrapolar EIS measurements 
were performed on the wall of the cervix for the detection of cervical intraepithelial neoplasia, and 
the distinction from normal epithelium using a custom-made four electrode portable probe. No 
study has been reported (to the authors’ knowledge) in the case of colorectal cancer. It is well 
known that the magnitude of the impedance and its dependence on frequency are a function of 
tissue composition. There have been demonstrations that different tissue structures are associated 
with different frequency bands within an impedance spectrum. At high frequencies (>1 GHz) 
molecular structure is the determining factor, whereas at low frequencies (<100 Hz) charge 
accumulation at large membrane interfaces dominates. At frequencies of a few kHz to 1 MHz, 
sometimes referred to as the dispersion region, cell structures are the main determinant of tissue 
impedance. Within the dispersion region, low-frequency current can be thought of as passing 
through the extracellular space. The current passes around the cells; the resistance to flow 
depends on the cell spacings and their arrangement. At higher frequencies, current can penetrate 
the cell membranes and hence passes through both intracellular and extracellular spaces. (Duck 
FA. 1990, Foster KR and Schwan HP 1989). It is, therefore, hypothesised that the resistivity of the 
epithelial surface is diminished with precancerous development, hence this dispersion becomes 
smaller with advancing pathology. 
 
Conventionally, EIS is performed by applying sinusoidal currents of different frequencies to a pair 
of electrodes and recording the voltage drop across two other electrodes in the vicinity. The ratio of 
the voltage and current yields a complex transfer impedance. This impedance is complex due to 
the fact that living tissues demonstrate capacitive and resistive properties. The former 
demonstrates a polarisable medium with respect to charges, while the latter indicates a direct flow 
of charge carriers. This leads to the recorded voltage having a phase difference with the applied 
current. Having separate current-carrying and voltage-recording electrodes, the effect of contact 
impedance which would otherwise dominate the recording in small electrodes is suppressed. In 
biological tissues, given that polarisation is not instantaneous and varies at different frequencies, 
the concepts of relaxation and dispersion may be introduced to explain the impedance profiles 
seen. Thus, to mathematically demonstrate the origin and nature of the complex impedance, in the 
presence of N frequency dispersions, the complex relative permittivity is given by (Gabriel et 
al,1996) : 
𝜖! = 𝜖! + 𝜎!𝑗𝜔𝜖! + ∆𝜖!1 + (𝑗𝜔𝜏!)(!!!!)!!!!  (1) 
where 𝜔 is the angular frequency, 𝜖! is the complex relative permittivity, ϵ! is the value of complex 
relative permittivity as ω → ∞, σ! is the static ionic conductivity, ϵ! is the permittivity of free space, ∆ϵ! = ϵ!-ϵ!, where ϵ! is the value of complex relative permittivity when ω → 0, j = -1, τ! is the 
corresponding relaxation time constant and α! is the corresponding broadening parameter in a 
given dispersion. Considering the geometrical capacitance, 𝜖! may be used to derive the complex 
impedance. In experiments, multiplying the recorded voltage by in-phase and quadrature signals, 
the real and imaginary components may be found. The magnitude of impedance can then be found 
by vector addition of the components. 
1.2 Competing Solutions 
In recent years, several methods have been proposed for real-time intra-operative tumour margin 
assessment including diffusive reflectance (Wilke et. al, 2009) radiofrequency-based detection 
(Allweis et al, 2008), and targeted fluorescence imaging (Van Dam GM et al, 2011). Each of these 
techniques is subject to particular strengths and limitations. However, a general  consensus has 
yet to be reached on the optimal strategy.  
Of particular clinical importance is the possibility to predict negative distal resection margin and 
negative circumferential resection margins. This can be considered especially for locally-advanced 
poorly-differentiated rectal tumours which have undergone neoadjuvant (preoperative) 
chemoradiation therapy. A major advantage of our proposed approach over previously proposed 
methods is the ability to provide instantaneous information regarding the state for the tissue, 
equivalent to a biopsy. Table 1 compares various methods for intraoperative tumour margin 
assessment with our proposed approach. 
 
Table 1: Comparison of Intraoperative Methods 
 
Method Advantage Disadvantage 
Radiofrequency-based 
detection (e.g. MarginProbe) 
• Real-time measurement • Technology not small 
enough to mount on an 
endoscope 
• No evidence that it will work 
on colorectal (only studies 
have been on breast) 
Real-time near infrared 
targeted fluorescence imaging 
• Good sensitivity and 
specificity in tumour margin 
detection 
• Compatible with minimally 
invasive cancer therapy 
• Limited detection depth 
• Requires fluorescent 
conjugate to be injected 
intravenously 
Intelligent Knife (iKnife) • Gives instant reading in the • Requires tissue ablation 
form of a mass spec profile before measurement can be 
carried out 
Bioimpedance • Can detect surface as well 
as depth, highly suitable for 
CRC 
• Small physical size 
• Technology is low cost 
• Does not require tissue 
alteration in order to obtain 
measurements 
 
 
• Technology for effective 
characterisation of the 
colorectal tissue does not 
currently exist 
 
2 Materials and Methods:  
22 colorectal tissue samples were obtained directly from theatre from patients diagnosed with an 
advanced-stage colon cancer who had undergone a surgical procedure for its removal. Visual 
inspections of the specimen by a pathologist were used to identify the two sites to be measured: 
the site of the cancer and approximately 10 cm away from the affected site, which was considered 
to be healthy non-cancerous tissue (Figure 1).  
 
 
 
 
 
 
 
 
 
 
Figure 1: Fresh colorectal specimen with identified sites marked by pins (colorectal cancer lesion 
marked by black pin and normal mucosa marked by white pin). 
EIS measurements were made by applying sinusoidal current of 12 µA amplitude at fourteen 
different frequencies from 76 Hz to 625 kHz with the ZedScan device (Zilico Ltd, Manchester, UK) 
(Figure 2) in test mode. The ZedScan device at the tip of the sensing area consists of a square 
arrangement of 4 gold electrodes, each 1 mm in diameter where the adjacent electrodes are 1.65 
mm apart. Each measurement was repeated three times and then averaged to provide a more 
accurate measure of trans-impedance. The purpose of obtaining measurements with the ZedScan 
device was primarily to determine the range of frequencies required for colorectal cancer and to 
generally evaluate the viability of the concept. The measurements were then downloaded on a 
personal computer using the software supplied with the ZedScan device. The collected data were 
then imported to Microsoft Excel software for analysis. 
 
	
	
 Figure 2: The ZedScan probe placed within its docking station. 
 
The two pre-identified areas (of the malignant lesion and normal mucosa) for each of the 22 
samples subsequently underwent formal histopathological analysis as per the normal clinical 
protocol. This consisted of formalin fixation, tissue processing, sectioning and subsequent 
haematoxylin and eosin staining and cover-slipping, thereby enabling microscopic analysis and 
histopathological confirmation of tissue type (Loughrey et al, 2014). Histopathological status of the 
22 tissue specimens were matched with corresponding impedance results for data analysis and 
correlation with tissue histology. SPSS (IBM, UK) was used to analyse the measurement data. As 
the recorded measurements were not normally distributed (as determined by Shapiro-Wilk test) the 
Wilcoxon signed-rank test for paired non-parametric data of small sample sets was used to test for 
differences between matched normal and malignant tissue at each frequency. A p-value less than 
0.05 was considered statistically significant. Receiver operating characteristic (ROC) curve and the 
area under the ROC curve (AUROC) were calculated by plotting the sensitivity against 1-specificity 
of the median results at the 14 different frequencies, in order to quantify the overall reliability of 
discrimination between normal and malignant colorectal tissue. 
3 Results:  
Data from 22 specimens (17 males, median age 77, age range 48-85) were originally obtained. 3 
specimens’ data sets were excluded from final data analysis as 2 were found to have no residual 
microscopic evidence of cancer following chemoradiotherapy (“complete responders” – samples 
13 and 18), and 1 was found to be non-malignant tissue (“benign villous adenoma” -sample 19) 
following formal histopathological assessment. This left 19 specimens for data analysis. Patient 
demographics and histopathological characteristics for each patient are summarized in Table 2.  
 
Sampl
e no. Age Sex 
Site of 
Cancer Type of Cancer 
T 
stage 
N 
stage 
Ischaemi
c time 
1 77 F Rectosig. Mod. diff. adenoCa 3 0 20 
2 48 F Rectum  Poorly diff. inv adenoCa 4 2 35 
3 54 F Sigmoid  Mod. diff. inv. adenoCa 1 0 15 
4 40 M Splen. Fl.  Poorly diff. adenoCa 3 0 45 
5 78 M Sigmoid  Mod. diff.adenoCa 4 0 30 
6 55 M Asc.col  Undifferentiated adenoCa 3 0 30 
7 85 M Caecum  Mod. diff. adenoCa 3 0 20 
8 72 F Caecum  Poorly diff. adenoCa. 4 2 20 
9 73 M Rectum  Mod. diff. adenoCa. 2 0 30 
10 69 M Rectum  Mod. diff. adenoCa 2 0 35 
11 73 F Rectosig.  Poorly diff. adenoCa 1 2 25 
12 75 M Caecum  Mod. diff. adenoCa 3 0 20 
13 41 M Rectum  COMPLETE RESPONDER N/A N/A 25 
14 68 M Asc.col  Mod.diff. inv.adenoCa 1 0 30 
15 64 M Rectum  Mod. diff. adenoCa 3 0 35 
16 38 M Asc. col  Poorly diff. adenoCa 4 1 45 
17 79 M Sigmoid  Mod. diff. adenoCa 3 0 30 
18 72 M Rectum  COMPLETE RESPONDER N/A N/A 20 
19 69 M Asc.col  VILLOUS ADENOMA N/A N/A 25 
20 51 M Rectum  Poorly diff. adenoCa 4 1 15 
21 71 M Rectum  Poorly diff. adenoCa 3 1 20 
22 65 M Rectum  Mod. diff. adenoCa 3 0 25 
 
Table 2: Patient demographics and histopathological characteristics of the 22 specimens (Mod. = 
moderately, diff. = differentiated, inv. = invasive, adenoCa = adenocarcinoma) 
 
The impedance spectra that were produced ranged from 100 Ω to 1000 Ω  over the 14 frequencies 
used. Mean and median impedances for the indicated 19 cancer sites and corresponding normal 
sites at each of the 14 different frequencies were calculated. Mean and median differences 
between cancer tissue and normal tissue bioimpedance across the 14 frequencies were calculated 
in all 19 specimens. The median impedance spectra results for the 19 cancers and corresponding 
normal tissue as well as the median impedances of the 2 complete-responder-specimens have 
been represented in figure 3. It was noted that although all 19 specimens did show differences 
between cancer and corresponding normal tissue impedances, 15 of the 19 specimens showed 
higher cancer impedances than corresponding normal tissue, whilst the remaining 4 specimens 
showed lower impedances than the normal tissue. 
 
          
Figure 3: Median impedance measures (with 5% error bars) over 14 standard frequencies, for 19 
cancerous samples, 2 complete responder samples and 19 normal tissue samples. 
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Table 3 shows the median impedance values along with the interquartile ranges at each of the 14 
varying frequencies for the 19 colorectal cancer lesions and corresponding normal tissue. 
Wilcoxon signed-rank test P-values for the differences in median impedances have also been 
represented, with statistically significant P-values (less than 0.05) noted at frequencies between 
152-625 KHz. 
 
In order to create a ROC curve to display the effectiveness of the Zedscan probe at detecting 
colorectal cancer from the 19 adenocarcinoma samples (figure 4), a reasonable cut-off impedance 
value of 350 Ohms was chosen. This cut-off value was chosen as it represented the level below 
which the majority of normal tissue impedances occurred, as well as being the level above which 
the majority of cancer impedances occur. The area under the ROC curve (AUROC) was calculated 
to be 0.7097, (where the tool can produce a perfect discrimination between the two groups, 
AUROC is 1). 
Applied 
Frequency
/ KHz 
Median (+ IQR) of 
impedances for 
19 cancer lesions' 
Median (+ IQR) 
of impedances 
for 19 benign 
lesions'  
Wilcoxon test P- 
values for 
differences at 
each frequency 
76 482 (341-845) 438 (314-542) 0.1119 
152 454 (325-766) 423 (314-456) 0.0382 
305 472 (316-749) 353 (280-402) 0.0242 
610 479 (313-734) 313 (247-354) 0.01 
1220 480 (313-715) 282 (234-342) 0.0074 
2441 473 (307-681) 262 (230-333) 0.0055 
4882 463 (302-640) 251 (226-326) 0.0055 
9765 439 (293-571) 242 (221-318) 0.0055 
19531 399 (286-526) 236 (215-311) 0.0089 
39062 359 (275-479) 229 (207-297) 0.0112 
78125 332 (261-424) 220 (197-280) 0.0126 
156250 294 (244-357) 208 (181-256) 0.0158 
312500 241,221-279 192 (164-226) 0.0364 
625000 256 (218-307) 173 (147-185) 0.0013 
 
Table 3: Median impedance measures along with the interquartile ranges (IQR) for the 19 
colorectal cancer (CRC) lesions and corresponding normal tissue. Wilcoxon rank test P-values for 
the differences in impedance have been stated. 
 
           
Figure 4: Receiver operating characteristic (ROC) curve comparing tissue analysed by the 
ZedScan probe as either malignant or normal CRC, based on the cut-off electrical impedance 
indicator of 350Ohms (AUROC = 0.7097). 
4 Discussion: 
The purpose of our prospective ex-vivo pilot study was to evaluate whether bioimpedance 
technology was able to discriminate between colorectal cancer tissue and normal colonic mucosa. 
The results presented here support other published data of larger studies, which report the effect 
of dysplastic changes of specific epithelial tissue on electrical impedance spectra (Brown et al, 
2000, Keshtkar et al, 2012, Mahara et al, 2015). Similarly, smaller studies looking at oesophageal 
cancers showed that oesophageal squamous epithelium also had much higher impedances than 
the dysplastic tissue and adenocarcinomas and squamous cell carcinomas (Knabe et al, 2013) 
Interestingly, our study of normal colonic columnar epithelium against colorectal 
adenocarcinomatous tissue showed that cancer in general had higher impedance than the normal 
columnar epithelium. Further work to compare the microscopic structure of the different types of 
colorectal tissue would facilitate further understanding of why these bioimpedance changes occur. 
Although 15 of the 19 adenocarcinoma samples showed bioimpedance spectra that were uniformly 
higher, 4 of the 19 adenocarcinoma samples showed bioimpedance spectra that were lower than 
the normal colorectal tissue bioimpedance spectra. It is unclear why this was the case. However, it 
may reflect the fact that 3 of these were found to be poorly or undifferentiated adenocarcinomas, 
whereas the majority of the adenocarcinomas that showed higher bioimpedances were moderately 
differentiated adenocarcinomas. It may be that the lack of differentiation in tissue structure affects 
the electrical resistance and subsequent bioimpedance characteristics of these samples. However, 
more work needs to be done to investigate this hypothesis further. 
Also of interest, the specimens where a complete pathological response was observed following 
chemoradiotherapy, demonstrated bioimpedence spectra that appears to be normalizing to that of 
normal tissue. However, this was in a very small sample (n=2) and would need further investigation 
with more samples before any firm conclusions could be drawn. 
Although our study presents promising results, there are limitations that should be addressed. It 
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should be noted that our results are based on a small initial sample size of 22 surgically resected 
colorectal samples, of which 19 were histopathologically-proven colorectal cancer specimens. 
Additionally, although the ROC curve is a promising representation of our initial data, the 
specificities observed were moderate at the lower measured frequencies.  
Our specimens were collected immediately after surgical resection, there was some delay between 
the tissue initially losing its blood supply and the EIS measurements being obtained - an ischaemic 
time.  It is known that once ex-vivo, tissue cellular structure begins to change with increasing 
ischaemic times (Spruessel et al, 2004). Additionally, as malignant tissue is known to be highly 
vascularized, increasing ischaemic times may also result in dehydration of the tissue, which may in 
turn result in alteration of electrical conductivity and impedance measurement. Further work needs 
to be done to investigate the effect of ischaemic times on EIS measurements.  
Finally, it is worth noting that whilst the Zedscan tool enabled us to make reproducible 
measurements of bioimpedance in colorectal tissue, it has been ergonomically designed for the 
specific measurement of cervical tissue at colposcopy. Consequently, whilst the long probe is 
required for application down a colposcope, conversely it prohibits stable measurement of 
colorectal tissue, as pressure effects on the tip can result in altered measurements (Keshtkar and 
Keshtkar, 2009). The future development of bioimpedance technology that is designed to facilitate 
more controlled measurements of colorectal tissue may result in more sensitive readings. 
5 Conclusions  
Our initial pilot study is the first of its kind to show that EIS can discriminate between surgically 
resected colorectal cancer and normal colorectal mucosa in patients with confirmed colorectal 
cancer, in a real-time and non-invasive manner. Although our initial sample size was small, and 
various limitations of our study have been discussed, we believe that with further research and 
development of the biophysical software and its ergonomics, EIS technology may have the 
potential to provide a real-time virtual biopsy of colorectal tissue in the future. Further work is 
required to adapt the technology specifically for bowel cancer and to test it on a much wider 
pathological range of colorectal samples to validate this original study. We hope that by developed 
into an EIS probe that could be deployed down the working channel of an endoscope or integrated 
into robotic surgical tools, in order to provide a real-time virtual biopsy and diagnosis of colorectal 
cancer. 
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